This site is intended for healthcare professionals only
LoginRegister
CDSCO Clears AstraZenecas Imfinzi (Durvalumab) for Additional Cancer Indication in IndiaAstraZeneca Imfinzi plus chemotherapy gets USFDA nod for mismatch repair deficient advanced or...
Intas PharmaDemonstrate safety and adequacy of dose: CDSCO Panel Tells Intas Pharmaceuticals on Bevacizumab...
Biocon Biologics Secures BB+ Rating Upgrade from S&P on Improved Financial MetricsUSFDA issues 3 observations for Biocon Visakhapatnam API facility
CDSCO Panel Flags Ethnic Variability, Seeks More Data from Takeda for Fruquintinib Hard Capsule ApprovalTakeda signs option agreement with Ascentage Pharma to enter into exclusive global license for...
USFDA concludes inspection at Dr Reddys Labs Srikakulam API facilityCDSCO Panel advises Dr Reddy's Laboratories to Revise Phase III CT Protocol for Live Attenuated...
JP Nadda, Anupriya Patel preside over review meeting of Department of PharmaceuticalsJP Nadda, Anupriya Patel preside over review meeting of Department of Pharmaceuticals
CDSCO Panel Clears Bristol Myers Yervoy for Two New Cancer IndicationsUSFDA approves Bristol Myers Squibb Augtyro for NTRK-Positive Locally Advanced or Metastatic Solid...
JnJ completes acquisition of Halda Therapeutics, its novel platform for cancer treatmentSuven Pharma to buy 67.5 percent stake in Sapala Organics for Rs 229.5 crore
Setback to Sun Pharma as Fibromun, Nidlegy Trials Miss Key Endpoints in Cancer StudiesSun Pharma, Moebius Medical present positive data from phase 2b trial of MM-II in painful knee...
KMV Narayana Rao appointed as Vice President - ARD at NATCO Research CentreKMV Narayana Rao appointed as Vice President - ARD at NATCO Research Centre
Bayer-Regeneron Aflibercept 8 mg recommended for EU approval for third retinal indicationBayer gets Breakthrough Therapy designation in China for lung cancer drug BAY 2927088
CDSCO Panel Accepts Glenmarks Apremilast Trial Report, Seeks 2-Year PSUR DataInclude nebulization methodology, nebulizer types: CDSCO Panel Tells Glenmark pharmaceuticals on...
X